Robert Matthew Miller
Chief Tech/Sci/R&D Officer chez SCANCELL HOLDINGS PLC
Profil
Robert Matthew Miller is the founder of Fulcrum Pharma Plc and Artemida Pharma Ltd.
He is currently the Medical Director at Scancell Holdings Plc and a member of the American Society of Clinical Oncology, Inc. and the European Society for Medical Oncology.
Previously, he was the Director of Clinical Development at Protodigm Ltd., Chief Medical Officer at Opsona Therapeutics Ltd., and Chief Consultancy Physician at Aptiv Solutions, Inc. He holds a doctorate degree from the University of London and The Royal College of Surgeons of England.
Postes actifs de Robert Matthew Miller
| Sociétés | Poste | Début |
|---|---|---|
| SCANCELL HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 17/11/2020 |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
| Artemida Pharma Ltd. | Founder | - |
Anciens postes connus de Robert Matthew Miller
| Sociétés | Poste | Fin |
|---|---|---|
Aptiv Solutions, Inc.
 Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Aptiv Solutions, Inc. provides biological research and development services. It offers adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing, and the operational support of a global clinical research organization. The company was founded in 1983 and is headquartered in Reston, VA. | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Chief Tech/Sci/R&D Officer | - |
| Protodigm Ltd. | Corporate Officer/Principal | - |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Founder | - |
Formation de Robert Matthew Miller
| University of London | Doctorate Degree |
| The Royal College of Surgeons of England | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCANCELL HOLDINGS PLC | Health Technology |
| Entreprise privées | 7 |
|---|---|
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
| Protodigm Ltd. | |
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Aptiv Solutions, Inc. provides biological research and development services. It offers adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing, and the operational support of a global clinical research organization. The company was founded in 1983 and is headquartered in Reston, VA. | Commercial Services |
| Artemida Pharma Ltd. |
